Observation Should be Considered as an Alternative in Management of Renal Masses in Older and Comorbid Patients

European Urology

Volumn 55, Issue 6, 2009, Pages 1419-1429

  Beisland, Christian ^a,b   Hjelle, Karin M ^b   Reisæter, Lars A R ^b   Bostad, Leif ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Active surveillance; Delayed intervention; Follow up; Mortality; Natural history; Observation; Renal cell carcinoma; Small renal masses; Watchful waiting

Indexed keywords

WARFARIN;

ADULT; AGED; AORTA ANEURYSM; ARTICLE; ARTIFICIAL EMBOLISM; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; ENDOCRINE DISEASE; FEMALE; HEART DISEASE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; OBSERVATION; ORTHOPEDICS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; OBSERVATION; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR BURDEN;

EID: 65049084395     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.12.031     Document Type: Article

References (30)

1. Van Poppel H., and Joniau S. Is surveillance an option for the treatment of small renal masses?. Eur Urol 52 (2007) 1323-1330
2. Kunkle D.A., Egleston B.L., and Uzzo R.G. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 179 (2008) 1227-1233
3. Hollingsworth J.M., Miller D.C., Daignault S., and Hollenbeck B.K. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98 (2006) 1331-1334
4. Remzi M., Katzenbeisser D., Waldert M., et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int 99 (2007) 1002-1006
5. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170 (2003) 2217-2220
6. Nuttall M., Cathcart P., van der Meulen J., Gillatt D., McIntosh G., and Emberton M. A description of radical nephrectomy practice and outcomes in England: 1995-2002. BJU Int 96 (2005) 58-61
7. Thoroddsen A., Gudbjartsson T., Jonsson E., Gislason T., and Einarsson G.V. Operative mortality after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol 37 (2003) 507-511
8. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
9. Israel G.M., and Bosniak M.A. An update of the Bosniak renal cyst classification system. Urology 66 (2005) 484-488
10. Population statistics, life tables 2007. Statistics Norway web site. http://www.ssb.no/dode/. Accessed March 4, 2008.
11. Lee J.Y., Kim C.K., Choi D., and Park B.K. Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: a single-institution experience. Eur Radiol 18 (2008) 731-737
12. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 14 (1961) 1272-1294
13. Chawla S.N., Crispen P.L., Hanlon A.L., Greenberg R.E., Chen D.Y., and Uzzo R.G. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425-431
14. Abou Y.T., Kassouf W., Steinberg J., Aprikian A.G., Laplante M.P., and Tanguay S. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110 (2007) 1010-1014
15. Lamb G.W., Bromwich E.J., Vasey P., and Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomy-natural history, complications, and outcome. Urology 64 (2004) 909-913
16. Reznek R.H. CT/MRI in staging renal cell carcinoma. Cancer Imaging 4 Suppl A (2004) S25-32
17. Mueller-Lisse U.G., Mueller-Lisse U.L., Meindl T., et al. Staging of renal cell carcinoma. Eur Radiol 17 (2007) 2268-2277
18. Frank I., Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., and Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173 (2005) 1889-1892
19. Ficarra V., Novara G., Galfano A., Novella G., Schiavone D., and Artibani W. Application of TNM, 2002 version, in localized renal cell carcinoma: Is it able to predict different cancer-specific survival probability?. Urology 63 (2004) 1050-1054
20. Beisland C., Medby P.C., and Beisland H.O. Renal cancer-a retrospective study of 368 patients [in Norwegian]. Tidsskr Nor Laegeforen 122 (2002) 2431-2435
21. Beisland C., Medby P.C., Sander S., and Beisland H.O. Nephrectomy - indications, complications and postoperative mortality in 646 consecutive patients. Eur Urol 37 (2000) 58-64
22. Han K.R., Kim H.L., Pantuck A.J., Dorey F.J., Figlin R.A., and Belldegrun A.S. Use of American Society of Anesthesiologists' physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma. Urology 63 (2004) 841-846
23. Matsuzaki M., Kawano Y., Morikawa H., Shiga Y., Murata H., and Komatsu H. Conservative management of small renal tumors. Hinyokika Kiyo 53 (2007) 207-211
24. Wehle M.J., Thiel D.D., Petrou S.P., Young P.R., Frank I., and Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 64 (2004) 49-52
25. Volpe A., Panzarella T., Rendon R.A., Haider M.A., Kondylis F.I., and Jewett M.A. The natural history of incidentally detected small renal masses. Cancer 100 (2004) 738-745
26. Kunkle D.A., Crispen P.L., Chen D.Y., Greenberg R.E., and Uzzo R.G. Enhancing renal masses with zero net growth during active surveillance. J Urol 177 (2007) 849-853
27. Kouba E., Smith A., McRackan D., Wallen E.M., and Pruthi R.S. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177 (2007) 466-470
28. Crispen P.L., Viterbo R., Fox E.B., Greenberg R.E., Chen D.Y., and Uzzo R.G. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112 (2008) 1051-1057
29. Maturen K.E., Nghiem H.V., Caoili E.M., Higgins E.G., Wolf Jr. J.S., and Wood Jr. D.P. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 188 (2007) 563-570
30. Wood B.J., Khan M.A., McGovern F., Harisinghani M., Hahn P.F., and Mueller P.R. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol 161 (1999) 1470-1474